
Oncology NEWS International
- Oncology NEWS International Vol 11 No 4
- Volume 11
- Issue 4
American Cancer Society Asks $5.69 Billion for NCI
WASHINGTON-The American Cancer Society (ACS) has offered a 13-point legislative agenda for 2002. The agenda backs President Bush’s request that Congress provide the National Institutes of Health $27.3 billion for fiscal year (FY) 2003, thus completing the doubling of the agency’s budget over 5 years.
WASHINGTONThe American Cancer Society (ACS) has offered a 13-point legislative agenda for 2002. The agenda backs President Bush’s request that Congress provide the National Institutes of Health $27.3 billion for fiscal year (FY) 2003, thus completing the doubling of the agency’s budget over 5 years.
ACS also wants the House and Senate to appropriate $5.69 billion for the National Cancer Institute, an increase of almost 36% above the $4.725 billion sought by Mr. Bush for FY2003, which begins on Oct. 1.
ACS also advocates $199.6 million (+24.4%) for the National Center for Minority Health and Health Disparities and $5 billion for the Centers for Disease Control and Prevention (CDC). The CDC figure represents an increase of $700 million (+16.2%), of which $1 billion (+33.7%) would fund the agency’s chronic disease prevention and health promotion program. ACS seeks $348 million to fund CDC’s cancer prevention and control efforts, an increase of 29.4% above the FY2002 budget
The ACS also urges Congress to provide $130 million (+28.7%) to fund the National Tobacco Control Plan/Office of Smoking and Health; $60 million (+118.1) for nutrition and physical activity; and $50 million (+32.3%) for CDC’s race initiatives.
Articles in this issue
over 23 years ago
Virtual Shared Specimen Resource ‘Essential’over 23 years ago
DHA Conjugate Increases Paclitaxel Uptake by Tumor Cellsover 23 years ago
Letrozole Superior to Tamoxifen in Metastatic Breast Cancerover 23 years ago
S-8184 Paclitaxel Emulsion Promising in Phase I Studyover 23 years ago
HIV+ Veterans Have Higher Rates of Unusual Cancersover 23 years ago
Online Breast Cancer Support Groups Beneficialover 23 years ago
Survival Benefit With Capecitabine/Docetaxelover 23 years ago
FDA Approves Zometa for Cancer-Related Bone ComplicationsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































